Protein S-100b serum levels in trauma-induced brain death

Neurology

Volumn 60, Issue 6, 2003, Pages 947-951

  Dimopoulou, Ioanna ^a,b   Korfias, S ^a   Dafni, U ^a   Anthi, A ^a   Psachoulia, C ^a   Jullien, G ^a   Sakas, D E ^a   Roussos, C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S100B;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BRAIN DEATH; BRAIN INJURY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DETERIORATION; DISEASE SEVERITY; FEMALE; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MALE; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SEX;

EID: 0037465767     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000049931.77887.7F     Document Type: Article

References (26)

1. Zink BJ. Traumatic brain injury outcome: concepts for emergency care. Ann Emerg Med 2001;37:318-332.
2. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995;37:417-429.
3. Ikeda Y, Hayashi M, Dohi K, Matsumoto K. Biochemical markers for brain damage. Neurosurg Quart 2001;11:173-180.
4. Marshall LF, Marshall SB, Klauber MR, et al. A new classification of head injury based on computerized tomography. J Neurosurg 1991;75:S14-20.
5. Wijdicks EF. The diagnosis of brain death. N Engl J Med 2001;344:1215-1221.
6. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845.
7. Ingebrigtsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? J Neurol Neurosurg Psychiatry 1995;59:103-104. Letter.
8. Jackson RG, Samra GS, Radcliffe J, Clark GH, Price CP. The early fall in levels of S-100 beta in traumatic brain injury. Clin Chem Lab Med 2000;38:1165-1167.
9. Wiesmann M, Missler U, Gottmann D, Gehring S. Plasma S-100b protein concentration in healthy adults is age- and sex-independent. Clin Chem 1998;44:1056-1058.
10. Schafer BW, Heizmann CW. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 1996;21:134-140.
11. Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A. Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir (Wien) 1997;139:1161-1165.
12. Raabe A, Grolms C, Keller M, Dohnert J, Sorge O, Seifert V. Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir (Wien) 1998;140:787-792.
13. Raabe A, Grolms C, Seifert V. Serum markers of brain damage and outome prediction in patients after severe head injury. Br J Neurosurg 1999;13:56-59.
14. Herrmann M, Jost S, Kutz S, et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma 2000;17:113-122.
15. Rothoerl RD, Woertgen C, Holzschuh M, Metz C, Brawanski A. S-100 serum levels after minor and major head injury. J Trauma 1998;45:765-767.
16. McKeating EG, Andrews PJ, Mascia L. Relationship of neuron specific enolase and protein S-100 concentrations in systemic and jugular venous serum to injury severity and outcome after traumatic brain injury. Acta Neurochir Suppl (Wien) 1998;71:117-119.
17. Raabe A, Menon DK, Gupta S, Czosnyka M, Pickard JD. Jugular and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study. J Neurol Neurosurg Psychiatry 1998;65:930-932.
18. Raabe A, Grolms C, Sorge O, Zimmermann M, Seifert V. Serum S-100B protein in severe head injury. Neurosurgery 1999;45:477-483.
19. Woertgen C, Rothoerl RD, Metz C, Brawanski A. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma 1999;47:1126-1130.
20. Rothoerl RD, Woertgen C, Brawanski A. S-100 serum levels and outcome after severe head injury. Acta Neurochir Suppl 2000;76:97-100.
21. Pleines UE, Morganti-Kossmann MC, Rancan M, Joller H, Trentz O, Kossmann T. S-100b reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma 2001;18:491-498.
22. Raabe A, Seifert V. Fatal secondary increase in serum S-100B protein after severe head injury. J Neurosurg 1999;91:875-877.
23. Regner A, Kaufman M, Friedman G, Chemale I. Increased serum S100b protein concentrations following severe head injury in humans: a biochemical marker of brain death? Neuroreport 2001;12:691-694.
24. Sakas DE, Bullock MR, Teasdale GM. One-year outcome following craniotomy for traumatic hematoma in patients with fixed dilated pupils. J Neurosurg 1995;82:961-965.
25. Wijdicks EF. Brain death worldwide: accepted fact but no global consensus in diagnostic criteria. Neurology 2002;58:20-25.
26. Anderson RE, Hansson LO, Nilsson O, Dijlai-Merzoug R, Settergren G. High serum S100B levels for trauma patients without head injuries. Neurosurgery 2001;48:1255-1258.